Search

Your search keyword '"Matteoni, Silvia"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Matteoni, Silvia" Remove constraint Author: "Matteoni, Silvia"
39 results on '"Matteoni, Silvia"'

Search Results

5. Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2

8. CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL

11. Phase II multicentric Italian trial on repositioning of the antipsychotic drug chlorpromazine and its combination with temozolomide in patients with MGMT unmethylated glioblastoma: The RACTAC trial.

14. CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS SYNERGISM WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL

18. Additional file 3 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity

19. Additional file 4 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity

20. Additional file 7 of Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response

21. Additional file 2 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity

23. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro

26. Additional file 2: of The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

27. Additional file 1: of The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

28. Additional file 4: of The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

30. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

32. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

33. Abstract 4316: hMENA11acontributes to HER3-mediated resistance to PI3K inhibitors in HER2 overexpressing breast cancer cells

34. Abstract 2618: PTEN loss as a putative biomarker of synergistic growth inhibitory activity of combined MEK/ERK and PI3K/mTOR pathway blockade

37. Fishing for new Alzheimer’s drug targets in large proteomics and transcriptomics datasets using expert‐curated pathways and predicted interaction networks.

38. SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability

39. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy

Catalog

Books, media, physical & digital resources